Graf Akcie ANIP (ANI Pharmaceuticals Inc). Diskuze k akciím ANIP. Aktuální informace ANIP.

Základní informace o společnosti ANI Pharmaceuticals Inc (Akcie ANIP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 486.15M
Hodnota podniku (EV) 564.27M
Tržby 213.377M
EBITDA 47.528M
Zisk -17.22
Růst v tržbách Q/Q 0.32 %
Růst v tržbách Y/Y 8.01 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 2.64
EV/EBITDA 11.87
EV/EBIT N/A
PEG 4.10
Price/Sales 2.28
P/FCF 60.13
Price/Book 2.48
Účetní hodnota na akcii 15.51
Hotovost na akcii 1.02
FCF vůči ceně 1.66 %
Počet zaměstnanců 369
Tržba na zaměstnance 578.257k
Profit margin -10.82 %
Operating margin -4.85 %
Gross margin 58.19 %
EBIT margin -4.85 %
EBITDA margin 22.27 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -2.90 %
EPS - Očekávaný růst příští rok -27.84 %
Return on assets -3.69 %
Return on equity -8.76 %
ROIC -3.60 %
ROCE -2.65 %
Dluhy/Equity 1.36
Čistý dluh/EBITDA 14.03
Current ratio 2.14
Quick Ratio 1.39
Volatilita 4.05
Beta 1.07
RSI 73.59
Cílová cena analytiků 38
Známka akcie (dle analytiků) N/A
Insider ownership 5.03 %
Institutional ownership 78.34 %
Počet akcií 12.752M
Procento shortovaných akcií 6.06 %
Short ratio 9.20 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie ANIP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$206.547$201.576$176.842$128.622$76.322$55.97
Cost Of Goods Sold$63.154$73.024$79.032$48.78$12.692$11.473
Gross Profit$143.393$128.552$97.81$79.842$63.63$44.497
Research And Development Expenses$19.806$15.388$9.07$2.906$2.874$2.678
SG&A Expenses$55.843$44.063$31.58$27.829$21.156$17.935
Other Operating Income Or Expenses$-6.781-$-0.903$-6.685--
Operating Expenses$190.196$166.217$148.513$108.543$43.622$35.964
Operating Income$16.351$35.359$28.329$20.079$32.7$20.006
Total Non-Operating Income/Expense$-13.194$-15.308$-11.98$-11.401$-10.967$-0.627
Pre-Tax Income$3.157$20.051$16.349$8.678$21.733$19.379
Income Taxes$-2.937$4.557$17.425$4.744$6.358$-9.368
Income After Taxes$6.094$15.494$-1.076$3.934$15.375$28.747
Other Income------
Income From Continuous Operations$6.094$15.494$-1.076$3.934$15.375$28.747
Income From Discontinued Operations------
Net Income$5.997$15.34$-1.076$3.913$15.375$28.588
EBITDA$60.963$69.101$56.257$42.422$39.6$23.884
EBIT$16.351$35.359$28.329$20.079$32.7$20.006
Basic Shares Outstanding121212111111
Shares Outstanding121212121211
Basic EPS$0.51$1.31$-0.09$0.34$1.34$2.61
EPS - Earnings Per Share$0.50$1.30$-0.09$0.34$1.32$2.59
# 2020 2019 2018 2017 2016 2015
Current Ratio3.04320.92353.35493.224216.381714.7352
Long-term Debt / Capital0.45240.25440.53140.41560.41470.4325
Debt/Equity Ratio0.87290.92781.15310.71110.70860.7622
Gross Margin69.423963.773555.309362.074983.370579.5015
Operating Margin7.916417.541316.019415.610942.844835.7442
EBIT Margin7.916417.541316.019415.610942.844835.7442
EBITDA Margin29.515334.280431.81232.981951.885442.6729
Pre-Tax Profit Margin1.52859.94719.2456.746928.475434.6239
Net Profit Margin2.90357.61-0.60853.042220.144951.0774
Asset Turnover0.45220.46810.42910.39840.26750.2156
Inventory Turnover Ratio1.31131.80292.09481.8630.94811.5261
Receiveable Turnover2.86363.10873.00812.80253.47993.2358
Days Sales In Receivables127.4629117.4114121.3378130.2396104.8869112.7998
ROE - Return On Equity2.86387.8545-0.61572.31899.604520.5652
Return On Tangible Equity21.1428-195.60651.892-49.285916.739829.9823
ROA - Return On Assets1.33413.5982-0.26111.21855.389711.0754
ROI - Return On Investment1.56825.8565-0.28851.35525.621411.6704
Book Value Per Share17.585416.629614.985814.625413.909312.264
Operating Cash Flow Per Share-1.90782.2841.040.88-0.49963.0748
Free Cash Flow Per Share-1.9712.69410.53650.6744-0.58723.0112